» Articles » PMID: 31713815

Expression of the Tau Protein and Amyloid Protein Precursor Processing Genes in the CA3 Area of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat

Overview
Journal Mol Neurobiol
Date 2019 Nov 13
PMID 31713815
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the mechanisms underlying the selective susceptibility to ischemia of the CA3 region is very important to explain the neuropathology of memory loss after brain ischemia. We used a rat model to study changes in gene expression of the amyloid protein precursor and its cleaving enzymes and tau protein in the hippocampal CA3 sector, after transient 10-min global brain ischemia with survival times of 2, 7, and 30 days. The expression of the α-secretase gene was below control values at all times studied. But, the expression of the β-secretase gene was below the control values at 2-7 days after ischemia and the maximal increase in its expression was observed on day 30. Expression of the presenilin 1 gene was significantly elevated above the control values at 2-7 days after ischemia and decreased below the control values at day 30. Expression of the presenilin 2 gene showed an opposite trend to the expression of presenilin 1. Expression of the amyloid protein precursor gene after ischemia was at all times above the control values with a huge significant overexpression on day 7. Additionally, the expression of the tau protein gene was below the control values 2 days after ischemia, but the significant increase in its expression was observed on days 7-30. Data show that brain ischemia activates neuronal changes and death in the CA3 region of the hippocampus in a manner dependent on amyloid and tau protein, thus determining a new and important way to regulate the survival and/or death of ischemic neurons.

Citing Articles

A Look at the Etiology of Alzheimer's Disease based on the Brain Ischemia Model.

Pluta R Curr Alzheimer Res. 2024; 21(3):166-182.

PMID: 38963100 DOI: 10.2174/0115672050320921240627050736.


Melatonin Inhibits Hypoxia-Induced Alzheimer's Disease Pathogenesis by Regulating the Amyloidogenic Pathway in Human Neuroblastoma Cells.

Singrang N, Nopparat C, Panmanee J, Govitrapong P Int J Mol Sci. 2024; 25(10).

PMID: 38791263 PMC: 11121645. DOI: 10.3390/ijms25105225.


- and -Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimer's Disease-like Type.

Pluta R, Czuczwar S Int J Mol Sci. 2024; 25(6).

PMID: 38542064 PMC: 10970557. DOI: 10.3390/ijms25063091.


Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.

Czuczwar S, Kocki J, Miziak B, Bogucki J, Bogucka-Kocka A, Pluta R J Alzheimers Dis. 2024; 98(1):151-161.

PMID: 38393914 PMC: 10977426. DOI: 10.3233/JAD-231333.


Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest.

Pluta R, Czuczwar S Int J Mol Sci. 2024; 25(2).

PMID: 38279289 PMC: 10816023. DOI: 10.3390/ijms25021291.


References
1.
Pluta R . The role of apolipoprotein E in the deposition of beta-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease. Ann N Y Acad Sci. 2000; 903:324-34. DOI: 10.1111/j.1749-6632.2000.tb06383.x. View

2.
Weil Z . Ischemia-induced hyperglycemia: consequences, neuroendocrine regulation, and a role for RAGE. Horm Behav. 2012; 62(3):280-5. DOI: 10.1016/j.yhbeh.2012.04.001. View

3.
Knierim J . The hippocampus. Curr Biol. 2015; 25(23):R1116-21. DOI: 10.1016/j.cub.2015.10.049. View

4.
Kim J, Lee Y . Dementia and Death After Stroke in Older Adults During a 10-year Follow-up: Results from a Competing Risk Model. J Nutr Health Aging. 2018; 22(2):297-301. DOI: 10.1007/s12603-017-0914-3. View

5.
Pluta R, Barcikowska M, Januszewski S, Misicka A, Lipkowski A . Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's beta-amyloid-(1-42)-peptide. Neuroreport. 1996; 7(7):1261-5. DOI: 10.1097/00001756-199605170-00008. View